I was as surprised as many with it. I thought the call had a couple (minor) negatives but not to justify this magnitude of drop. 1-Reimbursement in China could take 5+ years to go nationally even regionally takes couple years. Peter has posted he thinks it could go faster http://www.siliconinvestor.com/readmsg.aspx?msgid=31343635 2-For IPF Phase 3 they'll only give out P3 design in 1H '18 which I'd suspect trial won't start till 2H '18 which is a lot later then I thought.
Again I don't think either of these points justified such a big drop.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.